Semnur Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2023 | $5.9M | $87.0M | $579.4K |
| Jun 2023 | $6.6M | $88.2M | $9.1K |
| Sep 2023 | $8.0M | $90.1M | $13.5K |
| Dec 2023 | $8.5M | $50.7M | $204.5K |
| Mar 2024 | $8.9M | $51.3M | $1.0K |
| Jun 2024 | $9.2M | $52.1M | $1.5K |
| Sep 2024 | $9.5M | $8.9M | $13.0K |
| Dec 2024 | $49.5M | $6.7M | $12.0K |
| Mar 2025 | $10.7M | $9.1M | $7.0K |
| Jun 2025 | $11.2M | $562.5K | $55.0K |
| Sep 2025 | $15.4M | $774.0K | $85.0K |
| Dec 2025 | $22.1M | $1.3M | $20.0K |
| Mar 2026 | $27.3M | $2.0M | $103.0K |
| Jun 2026 | $31.6M | $1.9M | $39.0K |